A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Cancidas is ongoing, Merck disclosed in its August 8, 2011, Form 10-Q filing…
A patent infringement suit filed by Merck & Co. Inc. against Apotex Corp. relating to Nasonex is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
Viacom International Inc.’s copyright and trademark infringement suits against Cablevision Systems Corp. are pending, Cablevision disclosed in its August 9, 2011, Form 10-Q filing with the U.S. Securities and Exchange…
A patent infringement suit filed by Merck & Co. Inc. against Hamni USA, Inc. relating to Nexium is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with…
Patent litigation between Teva and Amgen Inc. has been dismissed, the Company disclosed in its August 8, 2011 Form 10-Q filing with the U.S. Securities and Exchange Commission for the…
A two-count declaratory judgment action for non-infringement of U.S. Patent Nos. 6,916,941 and 7,420,069, which are listed in the U.S. Food and Drug Administration’s Orange Book for Lexapro, filed by…
A decision in Star Scientific, Inc.’s appeal to a ruling in its patent infringement suit against RJR Tobacco is pending, Reynolds American Inc. disclosed in its August 8, 2011, Form…
Patent litigation between Teva and Amgen Inc. relating to Neutroval(TM) (a recombinant form of human G-CSF) has been settled, Amgen disclosed in its August 8, 2011, Form 10-Q filing with…
A patent infringement suit filed by Merck & Co. Inc. against Sandoz Inc. relating to AzaSite is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing with the…
A patent infringement suit filed by Merck & Co. Inc. against Teva Parenteral Medicines, Inc. relating to Integrilin is pending, Merck disclosed in its August 8, 2011, Form 10-Q filing…